Parker-Hannifin Corp: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 6, 2024 and accepted by EDGAR at Feb 6, 2024, 07:41 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $4.82bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-07-01 to 2023-12-31 | $9.67bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-10-01 to 2023-12-31 | $3.10bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-07-01 to 2023-12-31 | $6.20bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-10-01 to 2023-12-31 | $806.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-07-01 to 2023-12-31 | $1.68bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | $965.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-31 | $1.94bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $129.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-01 to 2023-12-31 | $263.5m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | $186.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-01 to 2023-12-31 | $355.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $682.1m | us-gaap:ProfitLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | $1.33bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $5.23 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | $10.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $5.31 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | $10.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 130,367,351 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 130,314,326 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | $1.35bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $204.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-07-01 to 2023-12-31 | $381.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2023-07-01 to 2023-12-31 | $138.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $382.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $6.73bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $29.69bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $7.50bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $18.38bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-12-31 | $3.68bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-12-31 | $1.20bn | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-12-31 | $11.30bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-12-31 | 128,410,854 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000076334-24-000008. Last ingested by Listed: Nov 3, 2026, 18:50 ET. Listed shows no prices and gives no investment advice.